VICON INDUSTRIES INC /NY/ Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 4 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-04: Reporting owner PROVINSAL MARK S; Form 4; Security STOCK OPTION (RIGHT TO BUY); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-04: Reporting owner HORN PETER A; Form 4; Security STOCK OPTION (RIGHT TO BUY); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-04: Reporting owner MCGOWAN BRET M; Form 4; Security STOCK OPTION (RIGHT TO BUY); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2012-12-04: Reporting owner BADKE JOHN M; Form 4; Security STOCK OPTION (RIGHT TO BUY); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-04 | PROVINSAL MARK S Officer (SALES/MKTG DIRECTOR-VICON LTD.) | 4 | STOCK OPTION (RIGHT TO BUY) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 29,500 owned after | $2.62 exercise price | 2012-12-05 | |
| 2012-12-04 | HORN PETER A Officer (VP - OPERATIONS) | 4 | STOCK OPTION (RIGHT TO BUY) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,000 30,500 owned after | $2.62 exercise price | 2012-12-05 | |
| 2012-12-04 | MCGOWAN BRET M Officer (SENIOR VP SALES & MARKETING) | 4 | STOCK OPTION (RIGHT TO BUY) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,000 28,500 owned after | $2.62 exercise price | 2012-12-05 | |
| 2012-12-04 | BADKE JOHN M Officer (SENIOR VP FINANCE/CFO) | 4 | STOCK OPTION (RIGHT TO BUY) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 41,500 owned after | $2.62 exercise price | 2012-12-05 |